{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:54:34Z","timestamp":1791644074656,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41443-018-0107-6","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T17:02:54Z","timestamp":1547571774000},"page":"328-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Method and design of drug treatment research of subjective premature ejaculation in men differs from that of lifelong premature ejaculation in males: proposal for a new objective measure (part 1)"],"prefix":"10.1038","volume":"31","author":[{"given":"Marcel D.","family":"Waldinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave H.","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"107_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0022-5347(17)70462-4","volume":"50","author":"B Schapiro","year":"1943","unstructured":"Schapiro B. Premature ejaculation: a review of 1130 cases. J Urol. 1943;50:374\u20139.","journal-title":"J Urol"},{"key":"107_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/00926238908403817","volume":"15","author":"ML Godpodinoff","year":"1989","unstructured":"Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther. 1989;15:130.","journal-title":"J Sex Marital Ther"},{"key":"107_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/jsm.12524","volume":"11","author":"EC Serefoglu","year":"2014","unstructured":"Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. J Sex Med. 2014;11:1423\u201341.","journal-title":"J Sex Med"},{"key":"107_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pbb.2013.12.004","volume":"121","author":"MD Waldinger","year":"2014","unstructured":"Waldinger MD. Ejaculatio praecox, erectio praecox, and detumescentia praecox as symptoms of a hypertonic state in lifelong premature ejaculation: a new hypothesis. Pharmacol Biochem Behav. 2014;121:189\u201394.","journal-title":"Pharmacol Biochem Behav"},{"key":"107_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00041444-199800810-00007","volume":"8","author":"MD Waldinger","year":"1998","unstructured":"Waldinger MD, Rietschel M, Nothen MM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatr Genet. 1998;8:37\u201340.","journal-title":"Psychiatr Genet"},{"key":"107_CR6","unstructured":"Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition (DSM-5). Washington, DC: American Psychiatric Association; 2013. p. 443\u20136."},{"key":"107_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1743-6109.2006.00275.x","volume":"3","author":"MD Waldinger","year":"2006","unstructured":"Waldinger MD, Schweitzer DH. Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part I: validity of DSM-IV-TR. J Sex Med. 2006;3:682\u201392.","journal-title":"J Sex Med"},{"key":"107_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1743-6109.2006.00276.x","volume":"3","author":"MD Waldinger","year":"2006","unstructured":"Waldinger MD, Schweitzer DH. Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part II: proposals for DSM-V and ICD-11. J Sex Med. 2006;3:693\u2013705.","journal-title":"J Sex Med"},{"key":"107_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4111\/kju.2011.52.1.1","volume":"52","author":"MD Waldinger","year":"2011","unstructured":"Waldinger MD. Toward evidence-based genetic research on lifelong premature ejaculation: a critical evaluation of methodology. Korean J Urol. 2011;52:1\u20138.","journal-title":"Korean J Urol"},{"key":"107_CR10","volume-title":"Pra\u0308jaculin. Kombiniertes Epiphysen-Pra\u0308parat gegen Reizzusta\u0308nde am Genitale und Hypererotismus.","author":"B Schapiro","year":"1932","unstructured":"Schapiro B. Pra\u0308jaculin. Kombiniertes Epiphysen-Pra\u0308parat gegen Reizzusta\u0308nde am Genitale und Hypererotismus.. Hamburg: Chemische Farbrik Promonta G.m.b.H.; 1932."},{"key":"107_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1176\/ajp.151.9.1377","volume":"151","author":"MD Waldinger","year":"1994","unstructured":"Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994;151:1377\u20139.","journal-title":"Am J Psychiatry"},{"key":"107_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","volume":"16","author":"MD Waldinger","year":"2004","unstructured":"Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004;16:369\u201381.","journal-title":"Int J Impot Res"},{"key":"107_CR13","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14656566.2018.1494725","volume":"19","author":"MD Waldinger","year":"2018","unstructured":"Waldinger MD. Drug treatment options for premature ejaculation. Expert Opin Pharmacother. 2018;19:1077\u201385.","journal-title":"Expert Opin Pharmacother"},{"key":"107_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0166-4328(97)00183-6","volume":"92","author":"MD Waldinger","year":"1998","unstructured":"Waldinger MD, Berendsen HHG, Blok BFM, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998;92:111\u20138.","journal-title":"Behav Brain Res"},{"key":"107_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.ijir.3901023","volume":"15","author":"MD Waldinger","year":"2003","unstructured":"Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. J Impot Res. 2003;15:309\u201313.","journal-title":"J Impot Res"},{"key":"107_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.ijir.3900415","volume":"11","author":"CG McMahon","year":"1999","unstructured":"McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res. 1999;11:241\u20135.","journal-title":"Int J Impot Res"},{"key":"107_CR17","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/S0022-5347(01)63201-4","volume":"159","author":"CG McMahon","year":"1998","unstructured":"McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol. 1998;159:1935\u20138.","journal-title":"J Urol"},{"issue":"4","key":"107_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1037\/h0087604","volume":"10","author":"Barry A. Tanner","year":"1973","unstructured":"Tanner BA. Two case reports on the modification of the ejaculatory response with the squeeze technique. Psychother Res Practice. 1973;297:297.","journal-title":"Psychotherapy: Theory, Research & Practice"},{"key":"107_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0022-3999(84)90055-2","volume":"28","author":"AJ Cooper","year":"1984","unstructured":"Cooper AJ, Magnus RV. A clinical trial of the beta blocker propranolol in premature ejaculation. J Psychosom Res. 1984;28:331\u20136.","journal-title":"J Psychosom Res"},{"key":"107_CR20","first-page":"402","volume":"56","author":"SE Althof","year":"1995","unstructured":"Althof SE, Levine SB, Corty EW, Risen CB, Stern EB. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry. 1995;56:402\u20137.","journal-title":"J Clin Psychiatry"},{"key":"107_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/13651509809115376","volume":"2","author":"MD Waldinger","year":"1998","unstructured":"Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Intern J Psychiatry Clin Pract. 1998;2:287\u201393.","journal-title":"Intern J Psychiatry Clin Pract"},{"key":"107_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1743-6109.2005.00070.x","volume":"2","author":"MD Waldinger","year":"2005","unstructured":"Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A Multi-national population survey of Intravaginal Ejaculation Latency Time. J Sex Med. 2005;2:492\u20137.","journal-title":"J Sex Med"},{"key":"107_CR23","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1111\/j.1743-6109.2009.01392.x","volume":"6","author":"MD Waldinger","year":"2009","unstructured":"Waldinger MD, McIntosh J, Schweitzer DH. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med. 2009;6:2888\u201395.","journal-title":"J Sex Med"},{"key":"107_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1439-0272.1988.tb00695.x","volume":"20","author":"F Fanciullacci","year":"1988","unstructured":"Fanciullacci F, Colpi GM, Beretta G, Zanollo A. Cortical evoked potentials in subjects with true premature ejaculation. Andrologia. 1988;20:326\u201330.","journal-title":"Andrologia"},{"key":"107_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1439-0272.1986.tb01834.x","volume":"18","author":"GM Colpi","year":"1986","unstructured":"Colpi GM, Fanciullacci F, Beretta G, Negri L, Zanollo A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia. 1986;18:583\u20136.","journal-title":"Andrologia"},{"key":"107_CR26","volume-title":"Clomipramine vs placebo in the treatment of premature ejaculation","author":"RT Segraves","year":"1992","unstructured":"Segraves RT, Saran A, Segraves K, Maguire E. Clomipramine vs placebo in the treatment of premature ejaculation. Prague, Czechoslovakia: Paper presented at the meeting of the International Academy of Sex Research; 1992."},{"key":"107_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/285759","volume":"145","author":"A Mackenzie","year":"1995","unstructured":"Mackenzie A, Reynolds JD, Sutherland W. \u201cVariation in Male Mating Success on Leks\u201d. Am Nat. 1995;145:633\u201352.","journal-title":"Am Nat"},{"key":"107_CR28","unstructured":"Flamingo Maring Dance: \n                    https:\/\/www.youtube.com\/watch?v=CUb0evFZbNM"},{"key":"107_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2190\/CWK2-U7R6-VCE0-E47P","volume":"33","author":"L Doyal","year":"2003","unstructured":"Doyal L. Sex and gender: the challenges for epidemiologists. Int J Health Serv. 2003;33:569\u201379.","journal-title":"Int J Health Serv"},{"key":"107_CR30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0277-9536(00)00402-0","volume":"53","author":"S Payne","year":"2001","unstructured":"Payne S. \u201cSmoke like a man die like a man\u201d? A review of the relationship between gender, sex and lung cancer. Soc Sci Med. 2001;53:1067\u201380.","journal-title":"Soc Sci Med"},{"key":"107_CR31","unstructured":"Mos J, Olivier B, Bloetjes K, Poth M. Drug-induced facilitation of sexual behavior in the male rat: Behavioral and pharmacological integration. In: Slob AK, Baum MJ, editors. Psychoneuroendocrinology of growth and development. Bussum, The Netherlands: Medicom Europe; 1990. p. 221\u201332."},{"key":"107_CR32","unstructured":"Olivier B, Mos J. Animal psychobiology. In: Archer T, Hansen S, editors, Behavioral Biology: Neuroendocrine Axis. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1991."},{"key":"107_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF01255816","volume":"77","author":"A Agmo","year":"1989","unstructured":"Agmo A, Fernandeze H. Dopamine and sexual behavior in the male rat: a reevaluation. J Neural Transm. 1989;77:21\u201337.","journal-title":"J Neural Transm"},{"key":"107_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00428106","volume":"68","author":"S Ahlenius","year":"1980","unstructured":"Ahlenius S, Larsson K, Svensson L. Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior. Psychopharmacology. 1980;68:217\u201320.","journal-title":"Psychopharmacology"},{"key":"107_CR35","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1460-9568.2005.04252.x","volume":"22","author":"T Pattij","year":"2005","unstructured":"Pattij T, de Jong T, Uitterdijk A, Waldinger MD, Veening JG, van der Graaf PH, et al. Individual differences in male rat ejaculatory behavior: searching for models to study ejaculation disorders. Eur J Neurosci. 2005;22:724\u201334.","journal-title":"Eur J Neurosci"},{"key":"107_CR36","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.2174\/138161205774913363","volume":"11","author":"T Pattij","year":"2005","unstructured":"Pattij T, Olivier B, Waldinger MD. Animal models of ejaculatory behaviour. Curr Pharm Des. 2005;11:4069\u201377.","journal-title":"Curr Pharm Des"},{"key":"107_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1743-6109.2005.20353.x","volume":"2","author":"DL Patrick","year":"2005","unstructured":"Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005;2:358\u201367.","journal-title":"J Sex Med"},{"key":"107_CR38","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.eururo.2007.10.015","volume":"53","author":"F Giuliano","year":"2008","unstructured":"Giuliano F, Patrick DL, Porst H, La Pera G, Kokoszka A, Merchant S, et al. Premature ejaculation: results from a Five-country European observational study. Eur Urol. 2008;53:1048\u201357.","journal-title":"Eur Urol"},{"key":"107_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4111\/icu.2016.57.2.119","volume":"57","author":"PKC Janssen","year":"2016","unstructured":"Janssen PKC, Waldinger MD. The mathematical formula of the intravaginale ejaculation latency time (IELT) distribution of lifelong premature ejaculation differs from the IELT distribution formula of men in the general male population. Investig Clin Urol. 2016;57:119\u201328.","journal-title":"Investig Clin Urol"},{"key":"107_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0924-977X(98)00015-7","volume":"9","author":"J Mos","year":"1999","unstructured":"Mos J, Mollet I, JTBM Tolboom, Waldinger MD, Olivier B. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur Neuropsychopharmacol. 1999;9:123\u201335.","journal-title":"Eur Neuropsychopharmacol"},{"key":"107_CR41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00213-005-2186-6","volume":"179","author":"TR Jong de","year":"2005","unstructured":"de Jong TR, Pattij T, Veening JG, Waldinger MD, Cools AR, Olivier B. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. Psychopharmacology. 2005;179:509\u201315.","journal-title":"Psychopharmacology"},{"key":"107_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2007.08.019","volume":"576","author":"JD Olivier","year":"2007","unstructured":"Olivier JD, de Jong TR, Jos Dederen P, van Oorschot T, Heeren D, Pattij T, et al. Effects of acute and chronic apomorphine on sex behaviour and copulation-induced neural activation in the male rat. Eur J Pharmacol. 2007;576:61\u201376.","journal-title":"Eur J Pharmacol"},{"key":"107_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/7854_2010_116","volume":"8","author":"B Olivier","year":"2011","unstructured":"Olivier B, Chan JS, Snoeren EM, Olivier JD, Veening JG, Vinkers CH, et al. Differences in sexual behaviour in male and female rodents: role of serotonin. Curr Top Behav Neurosci. 2011;8:15\u201336.","journal-title":"Curr Top Behav Neurosci"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0107-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:28:49Z","timestamp":1684618129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0107-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0107-6","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Waldinger is an adviser of Emotional Brain B.V. and Sapphire Pharmaceuticals","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}